ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near San Antonio, TX, USA:

New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)

Bluestar Genomics has developed a non-invasive test that aids in detection of occult pancreatic cancer in patients with new onset t ...

Enrolling
Pancreatic Cancer
Other: MRI/Imaging
ClearNote Health

Shavano Park, Texas, United States and 4 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

San Antonio, Texas, United States and 22 other locations

This is an open-label, non-controlled study conducted in two parts - Part A (dose escalation) followed by Part B (dose expansion).

Active, not recruiting
Colorectal Cancer
Pancreatic Cancer
Drug: NBF-006

Phase 1

Nitto BioPharma

San Antonio, Texas, United States and 8 other locations

and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...

Enrolling
Advanced Pancreatic Cancer
Drug: Zimberelimab
Drug: Gemcitabine

Phase 1

Arcus Biosciences
Arcus Biosciences

San Antonio, Texas, United States and 17 other locations

A Phase 1/2 Open-label, Multi-center Study of the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and in Combination with Chemothe...

Enrolling
Metastatic Cancer
Head and Neck Cancer
Drug: LYT-200
Drug: Gemcitabine/nab-paclitaxel

Phase 1, Phase 2

PureTech Health

San Antonio, Texas, United States and 11 other locations

This study is to evaluate the safety and tolerability of RMC-9805 in adults with KRAS G12D-mutant solid tumors.

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-9805

Phase 1

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 6 other locations

The study is a first-in-human (FIH), open-label, multi-center phase 1/2 study of TSN1611 in subjects with KRAS G12D mutant advanced solid tumors. Thi...

Enrolling
Malignant Neoplasm
Drug: TSN1611

Phase 1, Phase 2

Tyligand Bioscience

San Antonio, Texas, United States and 2 other locations

This is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without bu...

Enrolling
Pancreatic Cancer
Combination Product: TTX-030, nab-paclitaxel and gemcitabine
Combination Product: TTX-030, budigalimab, nab-paclitaxel and gemcitabine

Phase 2

Trishula Therapeutics

San Antonio, Texas, United States and 45 other locations

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors.

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236

Phase 1

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 14 other locations

A Phase 1/2 study of MRTX1133 in solid tumors harboring a KRAS G12D mutation.

Enrolling
Pancreatic Adenocarcinoma
Non-small Cell Lung Cancer
Drug: MRTX1133

Phase 1, Phase 2

Mirati Therapeutics
Mirati Therapeutics

San Antonio, Texas, United States and 15 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems